BI Asset Management Fondsmaeglerselskab’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Buy
488,378
+92,215
+23% +$21.5M 0.98% 17
2026
Q1
$96.7M Sell
396,163
-56,423
-12% -$13.1M 1.01% 19
2025
Q4
$93.7M Buy
452,586
+41,073
+10% +$8.12M 0.83% 18
2025
Q3
$76.3M Buy
411,513
+84,355
+26% +$14.5M 0.69% 29
2025
Q2
$50M Sell
327,158
-89,910
-22% -$13.8M 0.49% 41
2025
Q1
$69.2M Buy
417,068
+34,980
+9% +$5.47M 0.78% 23
2024
Q4
$55.3M Buy
382,088
+53,677
+16% +$8.32M 0.58% 34
2024
Q3
$53.2M Sell
328,411
-10,401
-3% -$1.66M 0.92% 22
2024
Q2
$49.5M Sell
338,812
-2,937
-0.9% -$437K 0.81% 25
2024
Q1
$54.1M Buy
341,749
+57,543
+20% +$9.16M 1.02% 23
2023
Q4
$44.5M Buy
284,206
+105,409
+59% +$16.2M 0.95% 22
2023
Q3
$27.8M Sell
178,797
-52,307
-23% -$8.63M 0.65% 38
2023
Q2
$38.3M Buy
231,104
+46,448
+25% +$7.5M 0.91% 24
2023
Q1
$28.6M Sell
184,656
-2,420
-1% -$391K 0.76% 27
2022
Q4
$33M Buy
187,076
+16,028
+9% +$2.77M 0.88% 24
2022
Q3
$27.9M Buy
171,048
+19,205
+13% +$3.25M 1.42% 17
2022
Q2
$27M Buy
151,843
+16,107
+12% +$2.87M 1.15% 23
2022
Q1
$24.1M Buy
135,736
+6,672
+5% +$1.14M 0.92% 29
2021
Q4
$22.1M Sell
129,064
-5,900
-4% -$966K 0.81% 37
2021
Q3
$21.8M Sell
134,964
-2,721
-2% -$464K 0.83% 32
2021
Q2
$22.7M Buy
137,685
+6,681
+5% +$1.11M 0.87% 28
2021
Q1
$21.5M Sell
131,004
-51,641
-28% -$8.36M 0.88% 30
2020
Q4
$28.7M Sell
182,645
-18,115
-9% -$2.67M 1.25% 21
2020
Q3
$29.9M Sell
200,760
-8,118
-4% -$1.2M 1.36% 16
2020
Q2
$29.4M Sell
208,878
-14,120
-6% -$2.06M 1.51% 12
2020
Q1
$29.2M Sell
222,998
-26,689
-11% -$3.79M 1.74% 15
2019
Q4
$36.4M Buy
249,687
+26,340
+12% +$3.57M 1.72% 12
2019
Q3
$28.9M Buy
223,347
+5,764
+3% +$759K 1.42% 25
2019
Q2
$30.3M Sell
217,583
-3,984
-2% -$551K 1.44% 27
2019
Q1
$31M Buy
221,567
+79,867
+56% +$10.7M 1.56% 21
2018
Q4
$18.3M Buy
141,700
+1,400
+1% +$195K 1.17% 34
2018
Q3
$19.4M Buy
140,300
+20,300
+17% +$2.7M 1.21% 32
2018
Q2
$14.6M Sell
120,000
-2,000
-2% -$250K 1.04% 40
2018
Q1
$15.6M Buy
+122,000
New +$16.5M 1.21% 34
2017
Q4
Sell
-6,000
Closed -$780K 63
2017
Q3
$780K Hold
6,000
0.06% 62
2017
Q2
$794K Hold
6,000
0.06% 59
2017
Q1
$747K Sell
6,000
-13,850
-70% -$1.65M 0.05% 56
2016
Q4
$2.29M Sell
19,850
-19,800
-50% -$2.29M 0.18% 49
2016
Q3
$4.68M Sell
39,650
-14,800
-27% -$1.8M 0.39% 47
2016
Q2
$6.61M Sell
54,450
-376,100
-87% -$42.7M 0.61% 44
2016
Q1
$46.6M Sell
430,550
-68,500
-14% -$7.09M 3.51% 10
2015
Q4
$51.3M Sell
499,050
-88,900
-15% -$8.94M 4.07% 6
2015
Q3
$54.9M Buy
587,950
+21,000
+4% +$2.03M 5.16% 7
2015
Q2
$55.3M Sell
566,950
-167,900
-23% -$16.8M 4.91% 7
2015
Q1
$73.9M Buy
734,850
+163,200
+29% +$16.6M 7.22% 2
2014
Q4
$59.8M Buy
571,650
+41,400
+8% +$4.36M 6.62% 3
2014
Q3
$56.5M Sell
530,250
-18,700
-3% -$1.94M 6.84% 3
2014
Q2
$57.4M Buy
548,950
+22,100
+4% +$2.23M 6.25% 4
2014
Q1
$51.8M Buy
+526,850
New +$48.8M 6.26% 5

Other funds holding JNJ

BI Asset Management Fondsmaeglerselskab's JNJ Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Johnson & Johnson (JNJ) stake by 23% in Q2 2026, buying an estimated $21.5M and bringing the position to 488,378 shares worth $124M. The position accounts for 0.98% of the portfolio, ranked #17.

BI Asset Management Fondsmaeglerselskab first reported a position in JNJ in Q1 2014 and has held it in 49 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 488,378 shares of Johnson & Johnson worth $124M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 92,215 Johnson & Johnson shares in Q2 2026, an estimated $21.5M.
  • Johnson & Johnson made up 0.98% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #17 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Johnson & Johnson in Q1 2014 and has held it in 49 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.